An Ex-Commissioner’s Bleak Take On The State Of Biopharma Innovation

 
• By Michael McCaughan

Former US FDA Commissioner Robert Califf remains eager to encourage broader use of real-world evidence – but his blunt, pessimistic read on the state of biopharma innovation is remarkable coming from a former FDA head.

Robert Califf in fornt of FDA building
Robert Califf during his 2016-2017 tenure as FDA commissioner.

More from United States

More from North America